Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Parabilis Medicines Inc (PBLS)

Parabilis Medicines Inc (PBLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Parabilis Medicines: Q2 Earnings Snapshot AP - Thu Aug 13, 6:07AM CDT

Parabilis Medicines: Q2 Earnings Snapshot

PBLS : 37.22 (+0.40%)
Parabilis Medicines Reports Second Quarter 2026 Financial Results and Provides Business Updates GlobeNewswire - Thu Aug 13, 6:00AM CDT

Advanced zolucatetide across multiple Wnt/β-catenin-driven diseases, including progress toward planned Phase 3 registrational trial in desmoid tumors  Announced strategic research collaboration...

PBLS : 37.22 (+0.40%)
Parabilis Medicines Announces Closing of Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares GlobeNewswire - Thu Jun 11, 3:05PM CDT

CAMBRIDGE, Mass., June 11, 2026 (GLOBE NEWSWIRE) -- Parabilis Medicines, Inc. (Nasdaq: PBLS) (“Parabilis”), a clinical-stage biopharmaceutical company built to develop transformative medicines addressing...

PBLS : 37.22 (+0.40%)
Medicine labratory by gorodenkoff via iStock
How to Play PBLS Stock After the Parabilis IPO Barchart - Thu Jun 11, 2:12PM CDT

Parabilis stock soared on its Nasdaq debut, but a deeper dive suggests PBLS shares could extend gains further through the remainder of 2026.

KLRA : 18.51 (+3.18%)
PBLS : 37.22 (+0.40%)
MRNA : 64.46 (+1.80%)
Parabilis Medicines Announces Pricing of Upsized Initial Public Offering GlobeNewswire - Tue Jun 9, 7:22PM CDT

CAMBRIDGE, Mass., June 09, 2026 (GLOBE NEWSWIRE) -- Parabilis Medicines, Inc. (Nasdaq: PBLS) (“Parabilis”), a clinical-stage biopharmaceutical company built to develop transformative medicines addressing...

PBLS : 37.22 (+0.40%)

Barchart Exclusives

Micron Hits $1,000 Again as Wall Street Bets AI Has Broken the Memory Boom-and-Bust Cycle Barchart - 32 minutes ago
Micron's $1,000 breakthrough reflects a growing belief that AI has changed the memory cycle. New, higher price targets on Wall Street suggest the boom may have much further to run. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.